Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul

NCT00947362 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Wound Healing

Interventions

OTHER: Electro-thermo-coagulation
DRUG: DAC N-055
DRUG: saline

Sponsor

Waisenmedizin e. V. Promoting Access to Essential Medicine

Collaborators

[object Object]
[object Object]